423
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Design, Synthesis, and Biological Evaluation of Tryptanthrin Alkaloids as Potential anti-Diabetic and Anticancer Agents

, ORCID Icon, , , &
Pages 874-894 | Received 02 Aug 2020, Accepted 07 Dec 2021, Published online: 11 Jan 2022
 

Abstract

An efficient green chemical approach has been reported to synthesize tryptanthrin alkaloids, utilizing isatin and isatoic anhydride as a substrate in the presence of tetrabutylammonium salt-based ionic liquids (TBA-ILs) as catalyst and reaction medium under microwave conditions (MWs). The reaction proceeds evenly under mild conditions to provide the bioactive natural product tryptanthrins in excellent yields. Besides, the molecular docking studies show that all the synthesized scaffolds exhibit potential binding affinities toward α-amylase, α-glucosidase ligands, GLP-1, and EGFR receptors; the in-vitro α-amylase and α-glucosidase assays show positive inhibition. In addition, the in vitro anticancer activity against A-549 non-small lung cancer (NSLC) cell lines leads to excellent inhibition. The present findings show the therapeutic potential of the tryptanthrins for targeting antidiabetic and anticancer activities.

Acknowledgments

Thankful to Sophisticated instrumentation facility, SIF-VIT for providing NMR, GC-MS FT-IR, and other facilities.

Disclosure statement

The authors declare no competing financial interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.